Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 known ✓ | Q99720 | 4/20 | 0.40 |
| ▸ | HTR2A known ✓ | P28223 | 3/20 | 0.40 |
| ▸ | DRD3 known ✓ | P35462 | 1/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.45 |
| ▸ | NR2E1 | Q9Y466 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL11334625 | 0.99 | TLR8 (0.44) | TLR8NR2E1ALDH1A1LMNAKDM4E | |
| SCHEMBL10777924 | 0.89 | ALDH1A1 (0.50) | TLR8NR2E1ALDH1A1LMNAKDM4E | |
| Lactic Acid SCHEMBL1720336 | 0.80 | KDM4E (0.43) | TLR8ALDH1A1LMNAKDM4EKMT2A | |
| SCHEMBL10886126 | 0.78 | TLR8 (0.38) | TLR8NR2E1ALDH1A1LMNAKDM4E | |
| Hydrochloric Acid SCHEMBL10885463 | 0.77 | TLR8 (0.37) | TLR8ALDH1A1LMNAKDM4EKMT2A | |
| SCHEMBL10926264 | 0.77 | MAPT (0.43) | TLR8ALDH1A1LMNAKDM4EKMT2A | |
| Acridine SCHEMBL10926258 | 0.76 | ALDH1A1 (0.58) | TLR8ALDH1A1LMNAKDM4EKMT2A | |
| Lactic Acid SCHEMBL5515418 | 0.76 | ALDH1A1 (0.44) | TLR8ALDH1A1LMNAKDM4EKMT2A | |
| Hydrochloric Acid SCHEMBL11373808 | 0.76 | TLR8 (0.50) | TLR8NR2E1ALDH1A1LMNAKDM4E | |
| Lactic Acid SCHEMBL28885529 | 0.75 | ALDH1A1 (0.43) | TLR8ALDH1A1LMNAKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4065445-A | Pregnancy-specific β1 -glycoprotein and process for isolating it | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1977-12-27 | — | — | US | claimed |
| US-4041021-A | MULTISTAGE PRECIPITATION, DISPERSION, SEPARATION AND ELECTROPHORESIS | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1977-08-09 | — | — | US | claimed |
| US-3930953-A | GLUCOSE OXIDASE POOR IN CATALASE AND PROCESS FOR OBTAINING IT | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | claimed |
| US-3931399-A | MULTISTAGE FROM EXTRACTION OF HUMAN PLACENTAE | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | claimed |
| EP-1817339-B1 | PURIFICATION OF RECOMBINANT HUMAN FACTOR XIII | ZYMOGENETICS INC (US) | 2012-01-11 | — | — | EP | disclosed |
| EP-0603215-B1 | PURIFICATION OF FACTOR XIII | ZYMOGENETICS INC (US) | 1997-10-29 | — | — | EP | disclosed |
| US-5612456-A | PURIFYING FACTOR XIII FROM A BIOLOGICAL FLUID | ZYMOGENETICS, INC. (US) | 1997-03-18 | — | — | US | disclosed |
| EP-0603215-A1 | PURIFICATION OF FACTOR XIII. | ZYMOGENETICS INC (US) | 1994-06-29 | — | — | EP | disclosed |
| US-5204447-A | Precipitating by adjustment of pH to 5.5 to 6.5, recovering | ZYMOGENETICS, INC. (US) | 1993-04-20 | — | — | US | disclosed |
| WO-1993003147-A1 | PURIFICATION OF FACTOR XIII | ZYMOGENETICS, INC. (US) | 1993-02-18 | — | — | WO | disclosed |
| EP-0442964-A1 | PURIFICATION OF FACTOR XIII | ZYMOGENETICS, INC. (US) | 1991-08-28 | — | — | EP | disclosed |
| WO-1990005777-A1 | PURIFICATION OF FACTOR XIII | ZYMOGENETICS, INC. (US) | 1990-05-31 | — | — | WO | disclosed |
| US-4191533-A | Pregnancy-specific β1 -glycoprotein and process for isolating it | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1980-03-04 | — | — | US | disclosed |
| US-4065445-A | Pregnancy-specific β1 -glycoprotein and process for isolating it | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1977-12-27 | — | — | US | disclosed |
| US-4041021-A | MULTISTAGE PRECIPITATION, DISPERSION, SEPARATION AND ELECTROPHORESIS | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1977-08-09 | — | — | US | disclosed |
| US-4018885-A | Steroid-binding globulin and process for preparing it and antibodies thereto | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1977-04-19 | — | — | US | disclosed |
| US-3930953-A | GLUCOSE OXIDASE POOR IN CATALASE AND PROCESS FOR OBTAINING IT | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
| US-3931399-A | MULTISTAGE FROM EXTRACTION OF HUMAN PLACENTAE | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
| US-3931399-A | MULTISTAGE FROM EXTRACTION OF HUMAN PLACENTAE | BEHRINGWERKE AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
| US-3904751-A | Process for isolating a fibrin stabilizing factor from human placenta | BEHRINGWERKE AG | 1975-09-09 | — | — | US | disclosed |